alisporivir,
DEBIO-025,
MeAla(3)EtVal(4)-cyclosporin,
UNIL 025,
UNIL-025,
UNIL025,
Alisporivir,
Debio 025,
Debio-025,
UNII-VBP9099AA6,
254435-95-5,
DEB025,
VBP9099AA6,
CHEMBL1651956,
UNIL 025,
Alisporivir [USAN:INN],
UNIL-025,
DEB-025,
Alisporivir (USAN),
SCHEMBL6850787,
BDBM50339127,
DE-025,
CS-7501,
DB12139,
HY-12559,
D10087,
(3S,6S,9S,12R,15S,18S,21S,24S,27R,30S,33S)-25,30-diethyl-33-((1R,2R)-1-hydroxy-2-methylhex-4-enyl)-6,9,18-triisobutyl-3,21,24-triisopropyl-1,4,7,10,12,15,19,27,28-nonamethyl-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriacontan-2,5,8,11,14,17,20,23,26,29,32-undecaone,
(3S,6S,9S,12R,15S,18S,21S,24S,27R,30S,33S)-25,30-diethyl-33-((1R,2R,E)-1-hydroxy-2-methylhex-4-enyl)-6,9,18-triisobutyl-3,21,24-triisopropyl-1,4,7,10,12,15,19,27,28-nonamethyl-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriacontan-2,5,8,11,14,17,20,23,26,29,32-undecaone,
Cyclo(L-alanyl-D-alanyl-N-methyl-L-leucyl-N-methyl-L-leucyl-N-methyl-L-valyl-(2S,3R,4R,6E)-3-hydroxy-4-methyl-2-(methylamino)-6-octenoyl-(2S)-2-aminobutanoyl-N-methyl-D-alanyl-N-ethyl-L-valyl-L-valyl-N-methyl-L-leucyl),
Alisporivir [INN],
D0CE0O,
UNIL025,
MeAla(3)EtVal(4)-cyclosporin,
HIV infection therapy, Debiopharm,
[D-MeAla]3-[EtVal]4-Cyclosporin A,
CID 9920021,
CID11513676,
HCV infection therapy, Debiopharm/Novartis,
C499715,
C509971,